Mark Drugs Limited
Pharmaceutical company specializing in medicines, bio-chemicals, and other related products.
1995 | Active
Mark Drugs Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
- Paid Up Capital ₹ 4.21 M
- Company Age 30 Year, 1 Month
- Open Charges ₹ 3.60 M
About Mark Drugs
Mark Drugs Limited (MDL) is a Public Limited Indian Non-Government Company incorporated in India on 18 January 1995 and has a history of 30 years and one month. Its registered office is in Na, Telangana.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 4.21 M.
The company currently has active open charges totaling ₹3.60 M.
Anandam Dyavanapally and Rajalingam Dyavanapalli serve as directors at the Company.
Company Details
- Location Na, Telangana
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239TG1995PLC019228
- Company No.
019228
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Jan 1995
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Who are the key members and board of directors at Mark Drugs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anandam Dyavanapally  | Director | 18-Jan-1995 | Current |
| Rajalingam Dyavanapalli | Director | 18-Jan-1995 | Current |
Financial Performance of Mark Drugs.
Enhance accessibility to Mark Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mark Drugs?
Unlock access to Mark Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹3.60 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.36 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Feb 1999 | Canara Bank | ₹1.80 M | Open |
| 22 Feb 1997 | Canara Bank | ₹1.80 M | Open |
How Many Employees Work at Mark Drugs?
Unlock and access historical data on people associated with Mark Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mark Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mark Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Mark Drugs
Recent activity within the organization
- Charges
A charge with Canara Bank amounted to Rs. 1.80 M with Charge ID 90115779 was registered on 11 Feb 1999.
- Charges
A charge with Canara Bank amounted to Rs. 1.80 M with Charge ID 90115443 was registered on 22 Feb 1997.
- Director Appointment
Anandam Dyavanapally was appointed as a Director was appointed as a Director on 18 Jan 1995 & has been associated with this company since 30 years 1 month .
- Director Appointment
Rajalingam Dyavanapalli was appointed as a Director was appointed as a Director on 18 Jan 1995 & has been associated with this company since 30 years 1 month .
- Company Incorporation
Mark Drugs Limited was registered on 18 Jan 1995 with Roc Hyderabad & aged 30 years 1 month as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Mark Drugs Limited?
Mark Drugs Limited was incorporated on 18 Jan 1995.
What is authorized share capital and paid-up capital of Mark Drugs Limited?
The authorized share capital of Mark Drugs Limited is ₹ 6.00 M and paid-up capital is ₹ 4.21 M.
Who are the current board members & directors of Mark Drugs Limited?
Currently 2 directors are associated with Mark Drugs Limited.
- Anandam Dyavanapally
- Rajalingam Dyavanapalli
What is the registered address of Mark Drugs Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Mark Drugs Limited is N-1-192, Vivekgarchikkadpally Hyderabad Telanga India, Na, Telangana.
What is the corporate identification number (CIN) and company number of Mark Drugs Limited?
The corporate identification number (CIN) of Mark Drugs Limited is U24239TG1995PLC019228 and the company number is 019228 as per Ministry of Corporate Affairs (MCA).
What are the total open charges for Mark Drugs Limited?
As per the financial statements for fiscal Year 0, The total open charges for Mark Drugs Limited amount to ₹ 3.60 M.